Skip to main content

Peer Review reports

From: Adding rituximab to chemotherapy for diffuse large B-cell lymphoma patients in Indonesia: a cost utility and budget impact analysis

Original Submission
8 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
2 Feb 2022 Reviewed Reviewer Report - Paul C. Langley
6 Feb 2022 Reviewed Reviewer Report
28 Feb 2022 Reviewed Reviewer Report - Sameera Senanayake
1 Apr 2022 Author responded Author comments - Septiara Putri
Resubmission - Version 4
1 Apr 2022 Submitted Manuscript version 4
11 Apr 2022 Author responded Author comments - Septiara Putri
Resubmission - Version 5
11 Apr 2022 Submitted Manuscript version 5
Publishing
18 Apr 2022 Editorially accepted
25 Apr 2022 Article published 10.1186/s12913-022-07956-w

You can find further information about peer review here.

Back to article page